Naturally-occurring shikonin analogues--a class of necroptotic inducers that circumvent cancer drug resistance.

作者: Yanyan Xuan , Xun Hu

DOI: 10.1016/J.CANLET.2008.09.029

关键词: InducerCancerNecroptosisDrug resistanceATP-binding cassette transporterChemistryCell cultureCancer drugsApoptosisPharmacology

摘要: We previously reported that shikonin could circumvent drug resistance mediated by P-gp, Bcl-2 and Bcl-xL, induction of necroptosis. Here, we show the naturally-occurring analogues (deoxyshikonin, acetylshikonin, isobutyrylshikonin, beta,beta-dimethylacrylshikonin, isovalerylshikonin, alpha-methyl-n-butylshikonin) bypass not only Bcl-2, but also two additional important drug-resistant factors MRP1 BCRP1, The results strengthen previous findings necroptotic a broad spectrum cancer resistance.

参考文章(57)
Stavrovskaya Aa, Cellular mechanisms of multidrug resistance of tumor cells. Biochemistry. ,vol. 65, pp. 95- 106 ,(2000)
XP Guo, XY Zhang, SD Zhang, None, Clinical trial on the effects of shikonin mixture on later stage lung cancer Zhong xi yi jie he za zhi = Chinese journal of modern developments in traditional medicine / Zhongguo Zhong xi yi jie he yan jiu hui (chou), Zhong yi yan jiu yuan, zhu ban. ,vol. 11, pp. 598- ,(1991)
Ranjana Advani, Hussain I. Saba, Martin S. Tallman, Jacob M. Rowe, Peter H. Wiernik, Joseph Ramek, Kathleen Dugan, Bert Lum, Jenny Villena, Eric Davis, Elisabeth Paietta, Manuel Litchman, Branimir I. Sikic, Peter L. Greenberg, Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar) Blood. ,vol. 93, pp. 787- 795 ,(1999) , 10.1182/BLOOD.V93.3.787.403K30_787_795
Kristina Viktorsson, Rolf Lewensohn, Boris Zhivotovsky, Apoptotic pathways and therapy resistance in human malignancies. Advances in Cancer Research. ,vol. 94, pp. 143- 196 ,(2005) , 10.1016/S0065-230X(05)94004-9
Curtis T. Keith, Alexis A. Borisy, Brent R. Stockwell, Multicomponent therapeutics for networked systems Nature Reviews Drug Discovery. ,vol. 4, pp. 71- 78 ,(2005) , 10.1038/NRD1609
Pierre Golstein, Guido Kroemer, A multiplicity of cell death pathways EMBO reports. ,vol. 8, pp. 829- 833 ,(2007) , 10.1038/SJ.EMBOR.7401042
Ling Li, Qiangrong Pan, Meng Sun, Qinghua Lu, Xun Hu, Dibenzocyclooctadiene lignans — A class of novel inhibitors of multidrug resistance-associated protein 1 Life Sciences. ,vol. 80, pp. 741- 748 ,(2007) , 10.1016/J.LFS.2006.11.002
Peter Hersey, Xu Dong Zhang, Overcoming resistance of cancer cells to apoptosis. Journal of Cellular Physiology. ,vol. 196, pp. 9- 18 ,(2003) , 10.1002/JCP.10256
Guido Kroemer, Lorenzo Galluzzi, Catherine Brenner, Mitochondrial Membrane Permeabilization in Cell Death Physiological Reviews. ,vol. 87, pp. 99- 163 ,(2007) , 10.1152/PHYSREV.00013.2006
Lisa M. Coussens, Zena Werb, Inflammation and cancer Nature. ,vol. 420, pp. 860- 867 ,(2002) , 10.1038/NATURE01322